Earnings2395SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.
SHIN Nippon Biomedical Reports Q1 FY2027 Earnings Presentation: Revenue of 7.9 billion
TOKYO, Aug 05 (Pulse News Wire) – SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395.T) released its earnings presentation for Q1 FY2027.
Revenue was ¥7.9 billion. Operating profit was -¥590 million. Ordinary profit was ¥1.4 billion. Net profit was ¥1.1 billion.
Total assets stood at ¥4.8 billion.
Financial results — FY2027/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥7,868M | +21.5% |
| Operating profit | ¥521M | +1433.0% |
| Net profit | ¥308M | n/a |
Next period forecast
Revenue
¥38,000M
+16.8%Op. profit
¥3,000M
+13.0%Net profit
¥3,500M
-23.4%Figures in millions of yen
End of article